Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
G.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.438NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.178NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.208NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.197NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.491NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EV.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21359South Korea
P.1.8 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.8.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.75.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CY.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FR.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBJ.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GJ.1.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CK.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.56.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.13.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.37NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CK.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.11.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDLNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.29.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.29.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.10.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.10.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.56NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.112NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.123NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.143NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.48NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.46.6.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.112.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.360NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.49NWon-NGTTGCGACTACGTGATGAGG20552884928830R-2683.5South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used